Gregory I. Frost
2010
In 2010, Gregory I. Frost earned a total compensation of $764.8K as President and Chief Executive Officer at Halozyme Therapeutics, a 14% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $80,000 |
|---|---|
| Option Awards | $280,480 |
| Salary | $396,590 |
| Other | $7,723 |
| Total | $764,793 |
Frost received $396.6K in salary, accounting for 52% of the total pay in 2010.
Frost also received $80K in non-equity incentive plan, $280.5K in option awards and $7.7K in other compensation.
Rankings
In 2010, Gregory I. Frost's compensation ranked 6,245th out of 10,439 executives tracked by ExecPay. In other words, Frost earned more than 40.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,245 out of 10,439 | 40th |
Division Manufacturing | 2,251 out of 3,838 | 41st |
Major group Chemicals And Allied Products | 501 out of 926 | 46th |
Industry group Drugs | 314 out of 685 | 54th |
Industry Biological Products, Except Diagnostic Substances | 63 out of 147 | 57th |
Source: SEC filing on April 11, 2013.
Frost's colleagues
We found seven more compensation records of executives who worked with Gregory I. Frost at Halozyme Therapeutics in 2010.
2010
Jonathan Lim
Halozyme Therapeutics
Chief Executive Officer
2010
Robert Little
Halozyme Therapeutics
Vice President and Chief Commercial Officer
2010
Jonathan Leff
Halozyme Therapeutics
Chief Medical Officer
2010
William Fallon
Halozyme Therapeutics
Vice President, Manufacturing & Operations
2010
H Shepard
Halozyme Therapeutics
Chief Scientific Officer
2010
Kurt Gustafson
Halozyme Therapeutics
Chief Financial Officer
2010
Michael LaBarre
Halozyme Therapeutics